NEW YORK (GenomeWeb News) – Invitrogen has signed up ImaGenes as a distributor for its Gateway ORF clones in Europe, ImaGenes said.
The Gateway system is used in restriction-free cloning and protein expression. ImaGenes said it plans to distribute the clones through its web-based clone portal, called GenomeCube.
The Berlin-based company is a spin-off of RZPD German Resource Center for Genome Research, a former Invitrogen distributor, and through a tri-lateral agreement ImaGenes has taken over the European distribution rights from RZPD. The center shut down in July 2007 and transferred its services operations to ImaGenes and Atlas Biolabs.
Financial terms of the agreement were not released.